PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Guaifenesin and Codeine Phosphate Oral Solution USP
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Superpotent; sodium benzoate preservative
- Products
-
- Guaifenesin and Codeine Phosphate Oral Solution USP
- Company
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc
- Where it was sold
-
OH
States: Ohio
- Units affected
- 4080 Bottles
- About this recall
- Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16